Allakos Inc (NASDAQ:ALLK)’s traded shares stood at 1.94 million during the last session, with the company’s beta value hitting 1.14. At the close of trading, the stock’s price was $1.31, to imply an increase of 10.08% or $0.12 in intraday trading. The ALLK share’s 52-week high remains $3.40, putting it -159.54% down since that peak but still an impressive 58.78% since price per share fell to its 52-week low of $0.54. The company has a valuation of $116.39M, with an average of 1.88 million shares in intraday trading volume over the past 10 days and average of 547.91K shares over the past 3 months.

Analysts have given a consensus recommendation of Buy for Allakos Inc (ALLK), translating to a mean rating of 2.71. Of 4 analyst(s) looking at the stock, 0 analyst(s) give ALLK a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 3 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.25.

Allakos Inc (NASDAQ:ALLK) trade information

After registering a 10.08% upside in the last session, Allakos Inc (ALLK) has traded red over the past five days. The 5-day price performance for the stock is 98.48%, and 127.63% over 30 days. With these gigs, the year-to-date price performance is -52.01%. Short interest in Allakos Inc (NASDAQ:ALLK) saw shorts transact 1.99 million shares and set a 5.71 days time to cover.

The extremes give us $1 and $218 for target low and target high price respectively. As such, ALLK has been trading -16541.22% off suggested target high and 23.66% from its likely low.

Allakos Inc (ALLK) estimates and forecasts

Looking at statistics comparing Allakos Inc share performance against respective industry, we note that the company has outperformed competitors. Allakos Inc (ALLK) shares are 28.43% up over the last 6 months, with its year-to-date growth rate higher than industry average at 28.50% against 17.50%. Revenue is forecast to grow 51.90% this quarter before jumping 67.60% for the next one.

An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 0.51% for the past 5-year period. While 2024 is set for a 28.05% return in earnings, projections for the next 5 years are at 26.70% annually.

ALLK Dividends

Allakos Inc has its next earnings report out on 2024-Nov-11. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Allakos Inc (NASDAQ:ALLK)’s Major holders

Allakos Inc insiders hold 2.33% of total outstanding shares, with institutional holders owning 88.08% of the shares at 90.18% float percentage. In total, 88.08% institutions holds shares in the company, led by BVF INC/IL. As of 2024-06-30, the company held over 16.55 million shares (or 18.8006% of shares), all amounting to roughly $16.55 million.

The next major institution holding the largest number of shares is NEA MANAGEMENT COMPANY, LLC with 6.15 million shares, or about 6.9822% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $6.15 million.

We also have Fidelity Advisor Biotechnology Fund and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Allakos Inc (ALLK) shares. Going by data provided on Aug 31, 2024 , Fidelity Advisor Biotechnology Fund holds roughly 4.86 shares. This is just over 5.47% of the total shares, with a market valuation of $6.36 million. Data from the same date shows that the other fund manager holds a little less at 2.34, or 2.63% of the shares, all valued at about 3.07 million.